Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2002
10/01/2002US6458958 Process of preparing a piperidine derivative compound of the formula: acylating an .alpha.,.alpha.-disubstituted-methylbenzene derivative having the formula:
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction
10/01/2002US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance
10/01/2002US6458925 Peptide antagonists of zonulin and methods for use of the same
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458794 Potassium channel inhibitors
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
10/01/2002US6458761 Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect
10/01/2002US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus
10/01/2002US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458370 Use of microparticles combined with submicron oil-in-water emulsions
10/01/2002US6458363 Method to produce inactivated w/o emulsion adjuvated vaccines
10/01/2002US6458362 Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes
10/01/2002US6458361 Soaking in water, heating beyond boiling point, stirring, filtering
10/01/2002US6458360 Soluble complement regulatory molecules
10/01/2002US6458358 Compounds encoding the protective M-like protein of Streptococcus equi and assays therefor
10/01/2002US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002US6458338 Amino acid stabilized medicinal aerosol formulations
10/01/2002CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2220461C Therapeutic compounds comprised of anti-fc receptor antibodies
10/01/2002CA2168113C Therapeutic peptide derivatives
10/01/2002CA2145411C Viscous liquid xylitol compositions and process for preparing the same
10/01/2002CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
10/01/2002CA2065104C Erucyl, brassidyl and nervonyl derivatives
09/2002
09/26/2002WO2002075304A1 Method of examining allergic disease
09/26/2002WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
09/26/2002WO2002074971A1 Flavonoid compound and process for producing the same
09/26/2002WO2002074955A2 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
09/26/2002WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074835A1 Process for producing lactic acid oligomer
09/26/2002WO2002074806A2 New interferon beta-like molecules
09/26/2002WO2002074805A1 Soluble rage protein
09/26/2002WO2002074798A2 The genome of a bifidobacterium
09/26/2002WO2002074783A2 Modified interferon beta with reduced immunogenicity
09/26/2002WO2002074777A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
09/26/2002WO2002074776A2 Highly purified and crystalline form of harringtonine
09/26/2002WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074761A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility
09/26/2002WO2002074733A2 Tryptase-inhibitors
09/26/2002WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors
09/26/2002WO2002074725A1 Novel ligands of nuclear receptor superfamily, process for producing the same and use thereof
09/26/2002WO2002074346A2 Targeting chemical compounds to cells
09/26/2002WO2002074333A2 Mycobacterial extracts used for treating allergy
09/26/2002WO2002074332A2 Method to enhance the immunogenicity of an antigen
09/26/2002WO2002074331A2 Mutated mhc molecules for use in immune suppression
09/26/2002WO2002074330A2 Mycobacterrial estracts for treating autoimmune diseases
09/26/2002WO2002074328A1 Methods of treating respiratory conditions
09/26/2002WO2002074325A1 Patch for transcutaneous immunization
09/26/2002WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002WO2002074318A1 Il-12 expression controlling agents
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074311A1 Antitumoral, antiviral, antibacterial, antiparasitic, anti-inflammatory, immunomodulatory and antimicotic medicinal preparation, method for production and dosage forms thereof
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074283A1 Adjuvant emulsion and method of using said emulsion
09/26/2002WO2002074244A2 Transcutaneous immunostimulation
09/26/2002WO2002074239A2 Compositions and methods for the treatment and clinical remission of psoriasis
09/26/2002WO2002074238A2 Water soluble and palatable complexes
09/26/2002WO2002074231A2 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata
09/26/2002WO2002074034A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
09/26/2002WO2002062999A8 Proteins and nucleic acids encoding same
09/26/2002WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
09/26/2002WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002053581A3 Spliceosome mediated rna trans-splicing
09/26/2002WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus
09/26/2002WO2002026954A3 Truncated phosphodiesterase-7 polypeptides
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002WO2002024220A3 Vaccine comprising heat stress proteins from herbaceous plants
09/26/2002WO2002009751A3 COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF
09/26/2002WO2002000710A3 B7-like molecules and uses thereof
09/26/2002WO2001083775A3 Proteases
09/26/2002WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
09/26/2002WO2001047953A3 Antibodies against plasma cells
09/26/2002WO2001032156A3 Methods for treating fibroproliferative diseases
09/26/2002WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
09/26/2002WO2001017554A9 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 1172